إعلان
إعلان
PASG
Passage Bio, Inc. Common Stock
20.23
USDبرعاية
+1.90
+10.34%
٠٩ يناير, ١٥:٥٨ UTC -5
مغلق
بعد الإغلاق
20.52
+0.30
+1.48%
تقارير أرباح PASG
النسبة الإيجابية المفاجئة
PASG تفوق 13 من 23 آخر التقديرات.
57%
التقرير التالي
بيانات التقرير القادم
٠٢ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/-$2.62
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/+7.38%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/-34.50%
Passage Bio, Inc. Common Stock earnings per share and revenue
On ١٠ نوفمبر ٢٠٢٥, PASG reported earnings of -2.44 USD per share (EPS) for Q3 25, beating the estimate of -2.85 USD, resulting in a 14.57% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +14.84% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 المحللين forecast an EPS of -2.62 USD, with revenue projected to reach -- USD, implying an زيادة of 7.38% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
What were Passage Bio, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Passage Bio, Inc. Common Stock reported EPS of -$2.44, beating estimates by 14.57%, and revenue of $0.00, 0% as expectations.
How did the market react to Passage Bio, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 14.84%, changed from $6.71 before the earnings release to $7.70 the day after.
When is Passage Bio, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٠٢ مارس ٢٠٢٦.
What are the forecasts for Passage Bio, Inc. Common Stock's next earnings report?
Based on 8
المحللين, Passage Bio, Inc. Common Stock is expected to report EPS of -$2.62 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان